DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mustargen (Mechlorethamine) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Mustargen (Mechlorethamine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (5)

Reports by Reaction Type

Metaplasia (1)Adverse Drug Reaction (1)Breast Cancer in Situ (1)Oesophageal Stenosis (1)Chronic Lymphocytic Leukaemia (1)Fatigue (1)Bone Marrow Failure (1)Hypoxia (1)Fibrosis (1)Mucous Membrane Disorder (1)Atrial Septal Defect (1)Vomiting (1)

Possible Mustargen side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 42 year old female

Reactions: Atrial Septal Defect, Fatigue, Hypoxia, Breast Cancer in Situ, Fibrosis, Exercise Tolerance Decreased

Drug(s) suspected as cause:
Mustargen

Other drugs received by patient: Thyroid TAB; Lexapro (Escitalopram Ocalate); Calcium / Vitamin D (Lekovit CA); Levothyroxine Sodium



Possible Mustargen side effects in

Reported by a physician from Italy on 2012-05-11

Patient:

Reactions: Adverse Drug Reaction

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Doxorubicin HCL

Bleomycin Sulfate
    Indication: Hodgkin's Disease

Mustargen
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease



Possible Mustargen side effects in

Reported by a physician from Italy on 2012-05-11

Patient:

Reactions: Chronic Lymphocytic Leukaemia

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Bleomycin Sulfate
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Doxorubicin HCL

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Mustargen
    Indication: Hodgkin's Disease



Possible Mustargen side effects in 13 year old female

Reported by a physician from Italy on 2011-11-02

Patient: 13 year old female

Reactions: Mucosal Inflammation, Vomiting, Barrett's Oesophagus, Metaplasia, Oesophageal Stenosis

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Oncovin
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Prednisone TAB
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Vinblastine Sulfate
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Dacarbazine
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Procarbazine Hydrochloride
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Adriamycin PFS
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III

Mustargen
    Dosage: 6 courses
    Indication: Hodgkin's Disease Stage III



Possible Mustargen side effects in 40 year old male

Reported by a physician from Japan on 2011-10-06

Patient: 40 year old male

Reactions: Renal Disorder, Bone Marrow Failure, Mucous Membrane Disorder

Drug(s) suspected as cause:
Methotrexate Sodium
    Indication: Immunodeficiency

Methotrexate
    Indication: Hodgkin's Disease

Cyclosporine
    Indication: Immunodeficiency

Prednisone
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Immunodeficiency

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Immunodeficiency

Mustargen
    Indication: Diffuse Large B-Cell Lymphoma

Mustargen
    Indication: Hodgkin's Disease

Adriamycin PFS
    Indication: Hodgkin's Disease

Mustargen
    Indication: Immunodeficiency

Methotrexate Sodium
    Indication: Diffuse Large B-Cell Lymphoma

Cyclosporine
    Indication: Hodgkin's Disease

Oncovin
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Immunodeficiency

Adriamycin PFS
    Indication: Immunodeficiency

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Oncovin
    Indication: Immunodeficiency

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Oncovin
    Indication: Hodgkin's Disease

Adriamycin PFS
    Indication: Diffuse Large B-Cell Lymphoma

Procarbazine Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Hodgkin's Disease

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017